Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) ≠ 1931
  • (-) = Burg, S.H. van der

Refine Results

Resource Type

Availability

Creation Date

Show more

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(97 - 120 of 279)

Pages

T cells engaging the conserved Mhc class ib Molecule Qa-1(b) with TaP-independent Peptides are semi-invariant lymphocytes
The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer
Tumor-infiltrating lymphocytes, tumor-associated macrophages and HLA class 1 expression in breast cancer patients treated with neoadjuvant chemotherapy with or without zoledronic acid: A sub study of the NEOZOTAC trial
The importance of correctly timing cancer immunotherapy
Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia
The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
CD4(+) T Cell and NK Cell Interplay Key to Regression of MHC Class I-low Tumors upon TLR7/8 Agonist Therapy
Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors
The presence of human papillomavirus (HPV) in placenta and/or cord blood might result in Th2 polarization
Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment
Control of immune escaped human papilloma virus is regained after therapeutic vaccination
Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature
Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4(+) and CD8(+) T Cell Responses against Mouse Cytomegalovirus Infection
Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer
Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFN gamma- and TNF alpha-Mediated Antiproliferative Effects and Necroptosis
Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8(+) T Cells
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
Monitoring of the Immune Dysfunction in Cancer Patients
Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
The Breadth of Synthetic Long Peptide Vaccine-Induced CD8(+) T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection

Pages